Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model
- 25 August 2023
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 814, 137464
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cellsGene, 2018
- Understanding Dopaminergic Cell Death Pathways in Parkinson DiseaseNeuron, 2016
- Serotonin in Parkinson's diseaseBehavioural Brain Research, 2015
- Maintaining skeletal muscle mass: lessons learned from hibernationExperimental Physiology, 2014
- Activation of serum/glucocorticoid‐induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophyEMBO Molecular Medicine, 2012
- Significance of SGK1 in the regulation of neuronal functionThe Journal of Physiology, 2010
- Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?Neurobiology of Disease, 2007
- Sgk1, a cell survival response in neurodegenerative diseasesMolecular and Cellular Neuroscience, 2005
- Inhibition of tyrosine hydroxylase expression in α-synuclein-transfected dopaminergic neuronal cellsNeuroscience Letters, 2004
- α-Synuclein Aggregation: A Link Between Mitochondrial Defects and Parkinson's Disease?Antioxidants & Redox Signaling, 2003